Carolyn M. Jodka

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

Andrew A. Young, Bronislava Gedulin, Sunil Bhavsar et al. · Diabetes · 1999 · 442 citations

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

David G. Parkes, Richard Pittner, Carolyn M. Jodka et al. · Metabolism · 2001 · 242 citations

Gastrointestinal Peptide Hormone, Molecular Physiology, Biochemistry +10

Effects of PYY[3–36] in rodent models of diabetes and obesity

Richard Pittner, Candace X. Moore, Sunil Bhavsar et al. · International Journal of Obesity · 2004 · 219 citations

Obesity, Caloric Restriction, Metabolic Syndrome +14

Pharmacokinetic actions of exendin‐4 in the rat: Comparison with glucagon‐like peptide‐1

David G. Parkes, Carolyn M. Jodka, Pam Smith et al. · Drug Development Research · 2001 · 158 citations

Immunology, Peptide Science, Pharmacotherapy +18

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

Christine M. Mack, Candace X. Moore, Carolyn M. Jodka et al. · International Journal of Obesity · 2006 · 138 citations

Obesity, Metabolic Syndrome, Nutrition +11